CT evaluation of gastrointestinal stromal tumors treated with imatinib mesylate [1]

American Journal of Roentgenology

Volumn 185, Issue 5, 2005, Pages 1366-

  Erturk, Sukru Mehmet ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

CHI SQUARE TEST; COMPUTER ASSISTED TOMOGRAPHY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; LETTER; MCNEMAR TEST; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; NOTE; RADIOGRAPHY; SCINTISCANNING; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; DATA INTERPRETATION, STATISTICAL; FLUORODEOXYGLUCOSE F18; GASTROINTESTINAL STROMAL TUMORS; HUMANS; PIPERAZINES; PYRIMIDINES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33644839037     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.05.5145     Document Type: Letter

References (5)

1. Choi H, Chamsangavej C, de Castro Faria S, et al. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR 2004; 183:1619-1628
2. Hawass NE. Comparing the sensitivities and specificities of two diagnostic procedures performed on the same group of patients. Br J Radiol 1997; 70:360-366
3. Daly LE, Bourke GJ, McGilvray J. Interpretation and uses of medical statistics, 4th ed. Oxford, UK: Blackwell Scientific Publications, 2001:130-132
4. Fleiss JL. Statistical methods for rates and proportions, 2nd ed. New York, NY: John Wiley & Sons, 1981:19-49
5. Ichikawa T, Haradome H, Hachiya J, et al. Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology 1997; 202:655-662